Afficher la couverture 'A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide | Gamberi, Barbara' en grand format
/5

0 avis

A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide

Archive ouverte

Gamberi, Barbara | Berthou, Christian | Hernandez, Miguel | Semenzato, Gianpietro | Tholouli, Eleni | Hájek, Roman | Caers, Jo | Dimopoulos, Meletios | Minnema, Monique | Andreasson, Bjorn | Parreira, Joana | Crotty, Gerard | Remes, Kari | Kueenburg, Elisabeth | Rosettani, Barbara | Di Micco, Antonia | Peters, Sarah | Bacon, Pamela | Blau, Igor Wolfgang

Edité par CCSD ; Elsevier -

International audience. Lenalidomide plus dexamethasone is effective and well tolerated in relapsed/refractory multiple myeloma (RRMM). In this observational, noninterventional European post-authorization safety study, the safety profile of lenalidomide plus dexamethasone was investigated and compared with that of other agents in the treatment of RRMM in a real-world setting.

Consulter en ligne

Suggestions

Du même auteur

The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective

Archive ouverte | Caers, Jo | CCSD

International audience. : Smoldering multiple myeloma (SMM) is an asymptomatic clonal plasma cell disorder and bridges monoclonal gammopathy of undetermined significance to multiple myeloma (MM), based on higher lev...

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis

Archive ouverte | Kastritis, Efstathios | CCSD

International audience

AIM2 inflammasome is activated by pharmacological disruption of nuclear envelope integrity

Archive ouverte | Di Micco, Antonia | CCSD

International audience. Inflammasomes are critical sensors that convey cellular stress and pathogen presence to the immune system by activating inflammatory caspases and cytokines such as IL-1β. The nature of endoge...

Chargement des enrichissements...